The role of developing breast cancer in alteration of serum lipid profile

Journal of Research in Medical Sciences

Volumn 17, Issue 6, 2012, Pages 562-565

  Abdelsalam Dr , Kamal Eldin A ^a   Hassan, Ikhlas K ^b   Sadig, Isam A ^b  

^a Omdurman Ahlia University Sudan   (Sudan)

^b OMDURMAN ISLAMIC UNIVERSITY   (Sudan)

Author keywords

Breast cancer; High density lipoprotein; Lipid profile total cholesterol; Low density lipoprotein; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; PARITY; POSTMENOPAUSE; PREMENOPAUSE;

EID: 84865551809     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Executive Summary. Washington, DC: NIH Publication No. 01-3670, National Institutes of Health; 2001.
2. Birtcher KK, Bowden C, Ballantyne CM, Huyen M. Strategies for implementing lipid-lowering therapy: Pharmacy-based approach. Am J Cardiol 2000;85:30-5.
3. Drexel H. Reducing risk by raising HDL-cholesterol: The evidence. Eur Heart J Suppl 2006;8:F23.
4. Rader Daniel J. Raising HDL in clinical practice. 2004. Retrieved October 8, 2009. http://www.medscape.org/viewarticle/479499_5
5. MDRTC Lipid Measurement Fact Sheet. University of Michigan Health System. Retrieved October 8, 2009. http://www.med.umich.edu/mdrtc/cores/ChemCore/lipids.htm
6. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL Cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-1310.
7. Nelson DL, Cox MM. Lehninger, Principles of Biochemistry. 3rd ed. New York: Worth Publishing; 2000.
8. Nydegger UE, Butler RE. Serum lipoprotein levels in patients with cancer. Cancer Res 1972;32:1756-1760.
9. Tehrani AM, Farajzadegan Z, Rajabi FM, Zamani AR. Belonging to a peer support group enhance the quality of life and adherence rate in patients affected by breast cancer: A non-randomized controlled clinical trial. J Res Med Sci 2011;16:658-665.
10. Barclay M, Skipski VP. Lipoproteinins relation to cancer. Prog Biochem Pharmacol 1975;10:76-111.
11. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 2006;13:1033-1067.
12. Park SY, Kolonel LN, Henderson BE, Wilkens LR. Dietary fat and breast cancer in postmenopausal women according to ethnicity and hormone receptor status: The Multiethnic Cohort Study. Cancer Prev Res (Phila) 2012;5:216-228. Epub 2011 Dec 13.
13. Rifai N, Warnick GR, McNamara JR, Belcher JD. Measurement of low density lipoprotein cholesterol in serum: A status report. Clin Chem 1992;38:150-060.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative centrifuge. Clin Chem 1972;18:499-502.
15. Rodriguez-Pinilla SM, Sarrio D, Honrado E, Hardisson D, Calero F, Benitez J, et al. Prognostic significance of basallike phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 2006;12:1533-1539.
16. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer 2007;109:25-32.
17. Florenza AM, Branchi A, Sommaviva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 2000;30;141-145.
18. Paillasse MR, de Medina P, Amouroux G, Mhamdi L, Poirot M, Silvente-Poirot S. Signaling through cholesterol esterification: A new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion. J Lipid Res 2009;50:2203-2211.
19. Yancey PG, Jerome GW, Yu H, Griffin EE, Cox BE, Babaev VR, et al. Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI. J Lipid Res 2007;48:1140-1149.
20. Hasija K, Bagga HK. Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian J Clin Biochem 2005;20:61-66.
21. Boekholdt MS, Thompson JF. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res 2003;44:1080-1093.
22. Tornberg SA, Holm LE, Carstensen JM. Breast cancer risk in relation to serum cholesterol, serum beta lipoprotein, height, weight and blood pressure. Acta Oncol 1988;27:31-37.